Zurich Insurance Group completed its 8.1 billion pound acquisition of Beazley on 1 October. Beazley’s shares were suspended that morning and delisted from the London Stock Exchange the following day. Shareholders receive 1,310 pence per share, with settlement due by 15 October.
On the same day, nine directors stepped down from the Beazley board: the chair Clive Bannister, along with Rajesh Agrawal, Roy Clark, Pierre-Olivier Desaulle, Nicola Hodson, Carolyn Johnson, Fiona Muldoon, John Reizenstein and Cecilia Reyes Leuzinger. Five Zurich-nominated directors took their places: Patrick Manley, Earl Randall Clouser, Helen Pickford, Kristof Terryn and Claudia Cordioli.
The route to that morning is worth tracing because it says something about how these things actually go. Zurich’s first approach in January was at 1,230 pence per share, a premium of roughly 60 per cent on Beazley’s mid-January closing price of 820 pence. Beazley’s board rejected it. The boards agreed a sweetened 8.1 billion pound deal on 2 March, shareholders approved it on 22 April, and Zurich part-funded it with a 3.9 billion Swiss franc share issuance in March. The combined business is expected to write around 15 billion dollars in gross written premiums, with Beazley’s six Lloyd’s syndicates extending Zurich’s specialty reach.
A 60 per cent premium was not enough. That is the first lesson and it is one most sellers never get to learn, because most boards take the first number that looks extraordinary.
The second lesson is in what completion day actually does, and it is the part founders selling a business consistently underestimate.
The operating business did not change on 1 October. The syndicates carry on writing the same risks with the same underwriters and the same customers. What changed, in a single morning, is who is in the room where decisions get made. Nine people with institutional memory of the independent company left. Five people whose mandate comes from the buyer arrived.
Everything after that happens by a different process. The budget conversation, the question of which lines get capital, the appetite for a particular class of risk, the decision about a system or an office or a team, all of it now runs through a group framework and a group priority list. None of that is sinister. It is simply what being owned means, and it arrives on the day the money does, not gradually.
Any owner contemplating a sale should sit with that timing honestly. The price is negotiated over months and is the thing everybody concentrates on. The governance change is instantaneous, is barely negotiated at all, and is what you will actually live inside afterwards.
The few things worth fighting for in that part of the document are small and specific. Who stays on the board. What decisions still get made locally. How long the arrangement holds before it can be revisited.
One note of caution on the reporting. Trade coverage on the day was inconsistent about the chief executive position, with some outlets reporting Adrian Cox remaining in post and at least one reporting a change subject to regulatory approval. Worth verifying before relying on either.
The cheque is dated 15 October.
The board changed on the 1st.
Source: Reinsurance News, “Zurich completes £8.1bn Beazley takeover ahead of LSE delisting”
